| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.67 | 0.008 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |